Originally published by our sister publication, Pharmacy Practice News
The dexamethasone arm of the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was halted early because the anti-inflammatory drug improved survival in patients with severe respiratory complications of COVID-19.